Emergency treatment of anaphylaxis | May 2021
13. de Silva D, Singh C, Muraro A, et al.; European Academy of Allergy and
Clinical Immunology Food Allergy and Anaphylaxis Guidelines Group.
Diagnosing, managing and preventing anaphylaxis: Systematic review.
Allergy. 2020 Sep 2. doi: 10.1111/all.14580.
14. Association of Anaesthetists: Anaphylaxis and allergies
https://anaesthetists.org/Home/Resources-publications/Safety-
alerts/Anaesthesia-emergencies/Anaphylaxis-and-allergies
15. Ewan PW, Dugué P, Mirakian R, Dixon TA, Harper JN, Nasser SM. BSACI
guidelines for the investigation of suspected anaphylaxis during general
anaesthesia. Clin Exp Allergy. 2010;40(1):15–31.
16. Department of Health and Social Care. Guidance on the use of adrenaline
auto-injectors in schools. Available at:
https://www.gov.uk/government/publications/using-emergency-adrenaline-
auto-injectors-in-schools
17. Panesar SS, Javad S, de Silva D, et al; EAACI Food Allergy and Anaphylaxis
Group. The epidemiology of anaphylaxis in Europe: a systematic review.
Allergy. 2013;68(11):1353–61.
18. Turner PJ, Jerschow E, Umasunthar T, Lin R, Campbell DE, Boyle RJ. Fatal
Anaphylaxis: Mortality Rate and Risk Factors. J Allergy Clin Immunol Pract.
2017;5(5):1169–1178.
19. Pumphrey RS, Gowland MH. Further fatal allergic reactions to food in the
United Kingdom, 1999-2006. J Allergy Clin Immunol 2007;119(4):1018–9.
20. Harper NJN, Cook TM, Garcez T, et al. Anaesthesia, surgery, and life-
threatening allergic reactions: epidemiology and clinical features of
perioperative anaphylaxis in the 6th National Audit Project (NAP6). Br J
Anaesth. 2018 Jul;121(1):159–171.
21. Tejedor-Alonso MA, Farias-Aquino E, Pérez-Fernández E, Grifol-Clar E,
Moro-Moro M, Rosado-Ingelmo A. Relationship Between Anaphylaxis and
Use of Beta-Blockers and Angiotensin-Converting Enzyme Inhibitors: A
Systematic Review and Meta-Analysis of Observational Studies. J Allergy
Clin Immunol Pract. 2019;7(3):879–897.e5.
22. Pumphrey RS. Fatal anaphylaxis in the UK, 1992-2001. Novartis Found
Symp 2004;257:116-28; discussion 128–32, 157–60, 276–85.
23. Gupta R, Sheikh A, Strachan DP, Anderson HR. Burden of allergic disease in
the UK: secondary analyses of national databases. Clin Exp Allergy
2004;34(4):520–6.
24. Lee S, Bashore C, Lohse CM, et al. Rate of recurrent anaphylaxis and
associated risk factors among Olmsted County, Minnesota, residents: A
population-based study. Ann Allergy Asthma Immunol. 2016;117(6):655–660.
25. Motosue MS, Bellolio MF, Van Houten HK, Shah ND, Campbell RL. Risk
factors for recurrent anaphylaxis-related emergency department visits in the
United States. Ann Allergy Asthma Immunol. 2018;121(6):717–721.